FdaApplication
NDA 214846
Identifiers
- fda_app_no: NDA214846
Properties
| Property | Value |
|---|---|
| applicant_name | SUMITOMO PHARMA AMERICA INC |
| application_type | NDA |
| approval_date | 2021-05-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MYFEMBREE | ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX | 1MG;0.5MG;40MG | TABLET;ORAL |
1 product